Dry Eye Disease

Patient dosing is underway in a phase 2b/3 trial investigating ALY688 ophthalmic solution for the treatment of dry eye disease, according to a press release from Allysta Pharmaceuticals.

Study results showing efficacy of a dry eye nasal spray and a blog pondering the future of Beovu lead ophthalmology coverage for June.

In a multispecialty practice, most patients who are referred to us for dry eye disease have gone through multiple attempts at therapy.

A long time ago, in a galaxy far, far away, DED diagnosis and treatment was a spartan affair undertaken by a tiny cadre of Jedi doctors who were pitied by their doctor brothers and sisters if they, and their quest, were acknowledged at all.

Visual outcomes after cataract surgery depend on accurate planning.

AMELIA ISLAND, Fla. — In this video from Cataract Surgery: Telling It Like It Is, Richard L. Lindstrom, MD, discusses the utility of compounded pharmaceuticals in treating dry eye disease.

Data presented at the virtual Association for Research in Vision and Ophthalmology meeting showed that subjects dosed with Xiidra experienced improvement in dry eye disease and symptoms over 12 months.

ORLANDO – Two practitioners advocated for an ocular surface disease therapy package including four sessions with intense pulsed light and one with in-office thermal pulsation.

Patients treated with a nasal spray experienced improvement in signs and symptoms of dry eye disease by day 28 of treatment, according to a study.

A large proportion of university students in Israel and the U.S. reported eye fatigue, eyestrain, ocular discomfort, headaches and burning eyes when evaluated during the COVID-19 pandemic, according to findings presented at the virtual Association for Research in Vision and Ophthalmology meeting.